CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 50 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $2,418,000 | -3.5% | 119,496 | +11.6% | 0.00% | 0.0% |
Q1 2021 | $2,506,000 | -44.6% | 107,122 | -31.8% | 0.00% | -50.0% |
Q4 2020 | $4,526,000 | +24.5% | 157,181 | -12.4% | 0.00% | +100.0% |
Q3 2020 | $3,634,000 | -15.4% | 179,375 | +25.5% | 0.00% | -50.0% |
Q2 2020 | $4,293,000 | +58.8% | 142,880 | +66.1% | 0.00% | +100.0% |
Q1 2020 | $2,703,000 | -18.6% | 85,997 | +22.0% | 0.00% | 0.0% |
Q4 2019 | $3,320,000 | +1152.8% | 70,476 | +71.7% | 0.00% | – |
Q3 2019 | $265,000 | -47.4% | 41,050 | 0.0% | 0.00% | – |
Q2 2019 | $504,000 | – | 41,050 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |